Episode summary

Cheap Is a Warning, Not a Thesis | Adam Parker on What This Market Is Really Pricing

Excess Returns · · Guests: Adam Parker

Cheap Is a Warning, Not a Thesis | Adam Parker on What This Market Is Really Pricing – Excess Returns

Summary

Adam Parker argues that the market is not necessarily ignoring fundamentals; it may be pricing a distribution of 2030 or 2031 outcomes rather than today’s data. He rejects simple calendar rules like “sell in May,” says valuation by itself is a poor stock-picking tool, and frames cheapness as a warning sign unless estimates are too low. He also thinks the market often leads the economy, not the other way around, so stock price action can be more useful than economist forecasts.

A major theme is AI. Parker says only 9% of the top 3,000 public U.S. equities are generating meaningful AI revenue, so he thinks the full earnings and productivity impact is still ahead. He is cautious on software and prefers semiconductors, arguing that software companies face margin pressure, pricing pushback, and eventual revenue risk as customers build internal tools. He remains constructive on semis, especially Nvidia, and thinks AI infrastructure spending can support the group even if the market is already looking far ahead.

He also sees healthcare as his highest-conviction contrarian idea. Parker believes AI will improve productivity in drug distribution, managed care, diagnostics, and tools, and that aging demographics support demand. He favors spin-offs as another possible source of value creation and expects more companies to use them as AI and scale pressures reshape business structures.

Key takeaways

  • Adam Parker says the market may be discounting 2030 or 2031 fundamentals, so investors should not assume today’s price action is detached from fundamentals.
  • Parker says only 9% of the top 3,000 U.S. equities are generating meaningful AI revenue, which is why he thinks the AI earnings effect is still early.
  • He prefers semiconductors over software because software firms face margin pressure, pricing pushback, and possible sales erosion as customers build internal AI tools.
  • Parker’s highest-conviction out-of-consensus idea is healthcare, where he sees AI-driven productivity, aging demographics, and margin expansion.
  • He views valuation alone as a weak stock-picking signal and thinks investors should focus more on estimate achievability and incremental margins.

Notable quotes

“I just almost think it's arrogant now if you say I buy a stock cuz it's cheap”

— Adam Parker

“the stock market that leads the economic data not the other way around anyway”

— Adam Parker at 4:37

“We think only 9% 262 out of the top 3,000 public US equities are currently generating any meaningful AI revenue”

— Adam Parker

“our northstar to like semis over software”

— Adam Parker at 27:21

How the episode opens

It's easy to say, "Oh, the market's not trading on fundamentals. It's it's, you know, you know, uh, retail idiots or crypto bros or whatever people want to say on the institutional side when they're underperforming. But the the truth is it might be trading on fundamentals.

It might be trading on a distribution of outcomes of 2030 fundamentals or 2031 or something in the future. Valuation doesn't work to pick stocks. I mean, I don't know how many times you have to how many years you need to know that.

Like I mean, I I actually have kind of changed my view on that to the point of like I just almost think it's arrogant now if you say I buy a stock cuz it's cheap. We think only 9% 262 out of the top 3,000 public US equities are currently generating any meaningful AI revenue.

Adam, thanks for joining us and welcome back to Excess Returns. Thanks for having me. — So much for selling me and go away. Guess

I always think those things are a little rough. I mean, we we actually did some analysis on that point. Um and you need like a few hundred more years to prove it's statistically significant.

So, it's it's one of those things where like um you know, you just could have had some spurious things that happened and then people think it's a a trade. But yeah, I I don't I'm not a big believer that. I think we studied it's the third worst month out of the 12 in the last 100 years, but it's nowhere near statistically significant.

So I I I'm not a huge believer in those. That's a little astrological.

Yeah. Well, I kind of said it tongue and cheek because I know that you know at Trivari where you're focused on is analysis over antidotes combining quant and judgment and I think understanding you know what is different between sort of cyclical and structural in the markets.

From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →

Topics

  • ai fundamentals
  • ai bubble
  • ai capex returns
  • gross margin expansion
  • mag seven positioning

Companies and tickers mentioned

  • NVDA
  • Nvidia
  • SpaceX

Watch the episode

Watch “Cheap Is a Warning, Not a Thesis | Adam Parker on What This Market Is Really Pricing” on YouTube

Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.

More from Excess Returns

All Excess Returns episodes →

Excess Returns, this episode and its artwork belong to Excess Returns. Octagon is not affiliated with the show; this page is an independent summary.